Literature DB >> 6851407

Tricyclic antidepressants and supine, standing, and exercise plasma norepinephrine levels.

R C Veith, M A Raskind, R F Barnes, G Gumbrecht, J L Ritchie, J B Halter.   

Abstract

Fourteen depressed patients were treated for 1 to 8 wk (4.1 +/- 0.6, mean +/- SEM) with imipramine, doxepin, or amitriptyline to study the effects of tricyclic antidepressants (TCAs) on sympathetic nervous system (SNS) function. Eight had chronic but medically stable cardiac disease and six were medically healthy. Supine plasma norepinephrine (NE) and epinephrine (EPI) levels, mean arterial blood pressure (MAP), and heart rate were measured at rest, after standing, and during graded, supine maximal bicycle exercise. Eight nondepressed patients with cardiac disease were studied without drug intervention as controls. There were no baseline differences in any of these measures among the medically healthy depressed subjects, the depressed cardiac patients, and the eight nondepressed patients matched for cardiac disease. After TCAs, NE was increased by 51 +/- 6% of basal values and heart rate rose, but EPI and MAP were unchanged. The supine to 10-min standing increment in NE increased from 309 +/- 51 pg/ml at baseline to 406 +/- 55 pg/ml during TCA treatment. These findings are compatible with an increase in SNS outflow after TCAs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6851407     DOI: 10.1038/clpt.1983.104

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

Review 1.  Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy.

Authors:  P P Lamy
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

2.  Effects of antidepressants, but not psychopathology, on cardiac sympathetic control: a longitudinal study.

Authors:  Carmilla M M Licht; Brenda W J H Penninx; Eco J C de Geus
Journal:  Neuropsychopharmacology       Date:  2012-07-04       Impact factor: 7.853

3.  The effect of clorgyline on noradrenergic function.

Authors:  R J Ross; M Scheinin; P Lesieur; M V Rudorfer; R L Hauger; L J Siever; M Linnoila; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.